High Mark Wealth Management LLC Viking Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 4,260 shares of VKTX stock, worth $122,134. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,260
Previous 3,000
42.0%
Holding current value
$122,134
Previous $189,000
9.52%
% of portfolio
0.1%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
467Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$292 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$173 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$141 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$74.4 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$61.9 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.2B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...